MobileODT logo — A FemTech company. 
Creating a new paradigm in cervical canc...

MobileODT

A FemTech company. Creating a new paradigm in cervical cancer screening and treatment.

Founded 2017 Israel Israel 13 employees Series C Total: $14.13M AI, Biotechnology +3

General Information

Company Name MobileODT
Founded Year 2017
Location Israel Israel +2
Founders / Decision Makers
Team member
Employees 13
Industries AI, Biotechnology, Health Care +2
Funding Stage Series C
Social

Get notified when MobileODT moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About MobileODT

MobileODT, **founded in 2012**, is a biotechnology and healthcare startup with the slogan "Empowering healthcare providers everywhere with smart, connected visual diagnostic tools, improving access, reducing costs, and enhancing outcomes." The company has developed the Enhanced Visual Assessment (EVA) System, **garnering a $4.00M Series C investment on 12 August 2020** from notable investors including **Laerdal Million Lives Fund, OrbiMed, Tara Health Foundation, and Tristel**. EVA, an FDA-cleared mobile colposcope, has gained significant market share in the US, Africa, and India, with over 40,000 procedures conducted across 29 countries. Notably, **leading hospitals such as MD Anderson, Mount Sinai, and Apollo** utilize EVA, and the system is increasingly becoming a standard tool for visualization in the United States, with **over 20% of hospitals in New York State** offering Sexual Assault Forensic Examinations employing it. The company is rapidly expanding into new regions and developing visual-based applications for ENT, oral disease, and skin, signaling promising growth in the biotech and healthcare sectors.

Taxonomy: visual diagnostic tools, connected medical devices, FDA-cleared devices, telemedicine, global healthcare, hospital equipment, medical imaging, healthcare accessibility, patient outcomes, medical innovation, expanding markets, internet-connected devices, global health impact, digital health solutions

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Series C •••••• 4
Investor Investor Investor
•••• ••••
12 Aug 2020
Series B •••••• 1
Investor
11 Feb 2020
Series B •••••• 2
Investor
•••• ••••
05 Jul 2017
Grant •••••• 2
Investor
•••• ••••
04 Aug 2015
Seed Round •••••• 1 •••• •••• 01 Feb 2015

View All 6 Funding Rounds

MobileODT Alternatives & Competitors

MobileODT vs
Gynaecology Plus
Gynaecology Plus New Zealand

Women's Health Software Specialists - Gynaecology Plus and Maternity Plus

11 employees
Health Care
MobileODT vs
Visionflex
Visionflex Australia

Virtual care solutions including telehealth equipment, software, medical cameras, patient monitoring...

12 employees
Health Care, Health and Wellness
MobileODT vs
HealthDocs
HealthDocs South Africa

Delivering a consumer centric digital healthcare ecosystem to reduce the cost of care, improve acces...

3 employees
Health Care, Internet

FAQ About MobileODT

A FemTech company. Creating a new paradigm in cervical cancer screening and treatment.
MobileODT was founded in 2017.
MobileODT is headquartered in Israel.
MobileODT operates in the following industries: AI, Biotechnology, Health Care, Medical Devices, Machine Learning.
MobileODT has approximately 13 employees.
MobileODT has completed 6 funding rounds, raising a total of $14.13M. The latest funding stage is Series C.
Top alternatives and competitors to MobileODT include Gynaecology Plus, Visionflex, HealthDocs, Radisens Diagnostics, Hemex Health, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
MobileODT and Gynaecology Plus are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors MobileODT and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy